QuiaPEG Pharmaceuticals operates in medical technology. The company has developed a technological platform that is used to improve and develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Alex Cohen | 5,90 | 5,90 | 2024-03-26 |
| Avanza Pension | 4,53 | 4,53 | 2024-03-26 |
| Nordnet Pensionsförsäkring | 4,34 | 4,34 | 2024-03-26 |
| Johan Thorell | 3,73 | 3,73 | 2024-03-26 |
| Sarum Sok | 2,46 | 2,46 | 2024-03-26 |
| Nabi Sultani | 1,89 | 1,89 | 2024-03-26 |
| Markus Svensson | 1,61 | 1,61 | 2024-03-26 |
| Erik Fällström via bolag | 1,42 | 1,42 | 2024-03-26 |
| Samuel Stierndahl | 1,34 | 1,34 | 2024-03-26 |
| Anders Lindén | 1,34 | 1,34 | 2024-03-26 |